BMI1 and colorectal neoplasm: Although PTC209 does not bind to BMI1, it reduces both BMI1 and H2AK119ub1 levels and inhibits the self-renewal of colorectal cancer-initiating cells, resulting in the abrogation of colorectal tumors.